Paying user area
Try for free
Edwards Lifesciences Corp. pages available for free this week:
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Long-term (Investment) Activity Ratios
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value (EV)
- Price to FCFE (P/FCFE)
- Present Value of Free Cash Flow to Equity (FCFE)
- Return on Assets (ROA) since 2005
- Total Asset Turnover since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Edwards Lifesciences Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Statement
12 months ended: | Net sales | Operating income | Net income |
---|---|---|---|
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
- Net Sales
- Net sales exhibited a consistent upward trend over the entire period analyzed, starting from approximately 998 million US dollars in 2005 and increasing steadily to about 5.23 billion US dollars by the end of 2021. The growth was particularly pronounced after 2012, with sales rising from 1.90 billion in 2012 to over 5.23 billion in 2021, reflecting robust expansion. The annual increments became more substantial in later years, highlighting accelerated revenue generation over time.
- Operating Income
- Operating income data begins in 2015 and shows notable variability during the available years. In 2015, operating income was recorded at 751.2 million USD, significantly increasing to a peak of 1.09 billion USD in 2016. This was followed by a decline to 748.2 million USD in 2017. Subsequently, operating income rose sharply again to 1.15 billion USD in 2018, and although it decreased to 897.6 million USD in 2019, it surged to a high of 1.69 billion USD in 2021. This pattern suggests periods of strong operational efficiency interspersed with fluctuations, but with an overall tendency toward growth in recent years.
- Net Income
- Net income showed an overall increasing trend across the full timeline. Beginning at 79.3 million USD in 2005, net income rose irregularly in early years but attained significant growth from 2012 onwards. Notable milestones include a jump to 811.1 million USD in 2014, followed by a decrease in 2015 to 494.9 million USD, then a recovery and steady increase culminating in 1.5 billion USD in 2021. Despite some fluctuations, especially during mid-period years, the general progression indicates improving profitability and enhanced bottom-line performance. The net income trends parallel the sales and operating income growth, underscoring overall financial health improvement.
Balance Sheet: Assets
Current assets | Total assets | |
---|---|---|
Dec 31, 2021 | ||
Dec 31, 2020 | ||
Dec 31, 2019 | ||
Dec 31, 2018 | ||
Dec 31, 2017 | ||
Dec 31, 2016 | ||
Dec 31, 2015 | ||
Dec 31, 2014 | ||
Dec 31, 2013 | ||
Dec 31, 2012 | ||
Dec 31, 2011 | ||
Dec 31, 2010 | ||
Dec 31, 2009 | ||
Dec 31, 2008 | ||
Dec 31, 2007 | ||
Dec 31, 2006 | ||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
The financial data indicates a consistent upward trend in both current assets and total assets over the period from the end of 2005 through 2021.
- Current Assets
- Current assets showed steady growth, increasing from $514,200 thousand in 2005 to $3,180,700 thousand by 2021. Notably, there was an acceleration in growth starting around 2012, where current assets rose from approximately $1,291,900 thousand to $3,180,700 thousand over roughly nine years. A peak appears in 2014 at $2,294,600 thousand, followed by a slight decline in 2015, but the overall trajectory remains upward throughout the period.
- Total Assets
- Total assets followed a similar growth trajectory, increasing from $1,229,100 thousand in 2005 to $8,502,600 thousand in 2021. This growth appears to be somewhat more pronounced than that of current assets, particularly after 2012, where total assets jumped from approximately $2,221,500 thousand to over $8.5 billion by the end of 2021. The data shows occasional fluctuations, including a slight decrease in total assets during 2018 to 2019, but the overall trend remains strongly positive and indicative of asset base expansion.
- Comparative Insights
- While both current assets and total assets increased, total assets expanded at a faster rate, particularly evident in the last decade. This differential suggests an increase in non-current asset holdings or long-term investments relative to current assets, reflecting potential strategic asset acquisitions or capital investments driving growth. The firm's asset base more than sextupled over the 16-year span, signaling significant scaling and resource accumulation.
- Overall Financial Trends
- The progressive growth pattern points to an expansionary phase, with a growing capacity to support operational and investment activities. The increases suggest enhanced liquidity and financial strength, although periodic slight declines highlight the variable nature of asset accumulation, possibly influenced by market conditions or business restructuring initiatives.
Balance Sheet: Liabilities and Stockholders’ Equity
Edwards Lifesciences Corp., selected items from liabilities and stockholders’ equity, long-term trends
US$ in thousands
Current liabilities | Total debt | Stockholders’ equity | |
---|---|---|---|
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
The financial data reveals several notable trends regarding the company's current liabilities, total debt, and stockholders’ equity from 2005 to 2021.
- Current Liabilities
- Current liabilities increased overall during the period, starting at 194,200 thousand US dollars in 2005 and reaching 1,032,300 thousand US dollars by 2021. The growth was not linear, with fluctuations observed such as a peak at 1,402,900 thousand in 2017, followed by declines and subsequent increases. The general upward trajectory suggests expansion in short-term obligations or operational scale.
- Total Debt
- Total debt declined significantly from 316,100 thousand US dollars in 2005 to 41,800 thousand by 2010, indicating a reduction in borrowings during these years. However, from 2010 onwards, debt levels increased again, reaching 1,036,400 thousand in 2017, followed by a marked decrease and stabilization around 595,000 thousand by 2021. This pattern indicates cycles of deleveraging followed by increased borrowing and eventual stabilization.
- Stockholders’ Equity
- Stockholders’ equity showed a consistent and substantial growth throughout the entire period. Starting at 690,000 thousand US dollars in 2005, it rose steadily to 5,835,900 thousand by 2021. This consistent increase reflects accumulation of earnings and possibly equity financing, contributing to a strengthening capital base and improved financial position over time.
Overall, the data indicates that while the company has experienced growth in both liabilities and equity, stockholders’ equity has expanded at a more pronounced and stable rate than debt. The fluctuations in total debt and current liabilities may reflect strategic financing decisions and operational needs at various points. The robust increase in equity suggests strong profitability and capital retention during the period under review.
Cash Flow Statement
Edwards Lifesciences Corp., selected items from cash flow statement, long-term trends
US$ in thousands
12 months ended: | Net cash provided by operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
---|---|---|---|
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
The analysis of the cash flow components reveals distinct trends in operating, investing, and financing activities over the observed period.
- Operating Activities
-
Net cash provided by operating activities shows a generally upward trajectory across the years. Starting at $136.8 million in 2005, it demonstrates significant growth with some fluctuations, reaching a notable peak of approximately $1.022 billion in 2014. Despite some variability, the cash inflows from operations maintain a robust positive trend, culminating at $1.732 billion by the end of 2021. This suggests an improving operational cash generation capacity over time, reflecting potentially stronger earnings or more efficient working capital management.
- Investing Activities
-
The net cash flow from investing activities fluctuates considerably, predominantly reflecting outflows across most periods. Early years show relatively moderate outflows or even positive inflows, such as the $58.8 million inflow in 2008 and $40.1 million inflow in 2009. However, substantial negative cash flows are evident in numerous years, for instance, large outflows of $412.8 million in 2011, $647.2 million in 2016, and peaking at approximately $1.722 billion outflow in 2021. This pattern indicates significant investment activity, likely in property, plant, equipment, or acquisitions, with the increasing magnitude in recent years potentially indicating accelerated capital expenditure or strategic investments.
- Financing Activities
-
Cash flows from financing activities exhibit a predominantly negative trend throughout most of the timeframe. The initial year shows a positive inflow of $29 million; however, this reverses sharply in 2006 with a $193.6 million outflow, followed by consistent negative cash flows in most subsequent periods. Notable exceptions include a positive inflow of $34.9 million in 2012 and smaller inflows in 2013, which appear as isolated instances within a broader pattern of cash used for financing. The outflows range from moderate amounts to significant levels such as $1.101 billion in 2018. This persistent negative trend suggests ongoing repayments of debt, stock buybacks, dividend payments, or other reductions in financing sources.
Collectively, these patterns portray a company progressively enhancing operational cash generation while significantly investing in business growth or asset acquisition. Financing cash flows indicate a net reduction in financial liabilities or distributions to shareholders, with intermittent inflows possibly related to new debt issuances or equity financing. The interplay of these cash flow segments underlines active financial management aimed at supporting expansion while maintaining operational cash strength.
Per Share Data
12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
---|---|---|---|
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.
The analysis of the financial data reveals several notable trends in earnings per share (EPS) for the company over the period from 2005 to 2021. Both basic and diluted EPS exhibit a general upward trajectory, indicating improving profitability and shareholder value over these years.
- Basic Earnings Per Share (EPS)
-
From 2005 to 2009, basic EPS increased gradually from $0.11 to $0.34, showing steady growth in profitability. Between 2010 and 2013, the EPS continued to rise, reaching $0.59 in 2013, with a significant jump seen in 2014 at $1.27. This peak represents a notable spike compared to the prior years.
Following the peak, there was a decline in EPS in 2015 and 2016, decreasing to $0.77 and $0.89 respectively, before resuming a moderate upward trend from 2017 onward. The EPS rose consistently after 2016, reaching $2.41 by 2021, which is the highest value in the series, highlighting strong profitability growth in recent years.
- Diluted Earnings Per Share (EPS)
-
Similar to basic EPS, diluted EPS followed a comparable growth pattern. Beginning at $0.11 in 2005, it increased steadily to $0.33 by 2011. It then continued an upward path reaching $0.57 in 2013, and like basic EPS, it saw a sharp rise in 2014 to $1.25.
Diluted EPS showed a decline in 2015 to $0.75 and rose slightly to $0.87 in 2016. Thereafter, a consistent upward trend occurred, with diluted EPS reaching $2.38 by 2021. This trend underlines enhanced profit generation on a per-share basis after accounting for potential dilution effects.
- Dividend Per Share
-
No dividends were declared or reported throughout the entire data period, as indicated by the absence of values for dividend per share. This could suggest a strategy focused on reinvestment of earnings or other uses of capital rather than distribution to shareholders.
In summary, the EPS trends demonstrate sustained and significant growth in the company's profitability over the analyzed time span, particularly since the early 2010s. The absence of dividends during this period indicates that the company may prioritize growth reinvestment. The substantial increase in EPS by 2021 reflects positively on the company’s earnings performance and ability to generate shareholder value.